Research
Hormonal
Obesity is a causal factor for many types of cancer, including colorectal, endometrial, kidney, and postmenopausal breast cancer.
Maintaining a healthy weight reduces your risk of developing several common cancers, including colorectal, kidney, and postmenopausal breast cancer.
StrongSupportsVERY_HIGH confidence
There is convincing evidence for a role of obesity as a causal factor for many types of cancer including colorectum, endometrium, kidney, oesophagus, postmenopausal breast, gallbladder, pancreas, gastric cardia, liver, ovary, thyroid, meningioma, multiple myeloma, and advanced prostate cancers
Why this rating
Described as 'convincing evidence' by the IARC working group.
Source
Energy balance and obesity: what are the main drivers?
On behalf of the IARC working group on Energy Balance and Obesity et al. · Cancer Causes & Control · 2017
DOI 10.1007/s10552-017-0869-z
narrative_reviewCited 755×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Sustained positive energy balance (energy intake exceeding energy expenditure) is the primary driver of obesity and weight gain.Strong
- Limiting consumption of sugar-sweetened beverages (SSBs) is a critical intervention for weight control and obesity prevention.Good
- Moderate intensity physical activity (150-250 min/week) prevents weight gain, while >250 min/week is required for weight maintenance after loss.Good
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →